Position in GANX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$42,660
+$21,932 QoQ
Shares Held
21,015
+96.7% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 49 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,870,510 across 148 Biotechnology names. GANX ranks #89 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
29,790 | $3,954,026 | |
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in GANX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,660 | 21,015 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $20,728 | 10,685 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $95,594 | 54,008 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $42,841 | 23,801 | Shares | Defined | 2025-08-12 | |
| 2024-06-30 | $35,015 | 27,356 | Shares | Defined | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||